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Abstract
31P magnetic resonance spectroscopy (31P MRS) has been used to measure intramuscular
magnesium concentrations and muscle metabolism. Abnormal intramuscular magnesium has been
reported in several patient populations with suspected metabolic disorders. The purpose of this
study was to evaluate our ability to measure intramuscular magnesium and muscle metabolism in
the quadriceps muscles of healthy subjects, and to test whether these measurements were
influenced by prior exercise. Twelve normal, healthy male volunteers were tested in a 3 Tesla
magnet on four separate days. Resting [Mg2+] was calculated from the heights and frequency shifts
of the phosphate, phosphocreatine and ATP peaks. Phosphocreatine (PCr) recovery kinetics were
measured after 30-39 second bouts of isometric exercise. Thirty minutes prior to the 3rd test
session the subjects completed a 2 hour treadmill walk at 40-60% of heart rate reserve. Resting
[Mg2+] averaged 0.388 mM and had an interclass correlation coefficient between days (ICC) of
0.352. The mean end exercise PCr was 47.6% and the mean end exercise pH was 6.97. PCr
recovery averaged 39 seconds (p = 0.892) and had an ICC of 0.819. Prior long duration exercise
did not produce significant alterations in either PCr recovery kinetics or intracellular magnesium
levels (p = 0.440). In conclusion, the reproducibility of Resting [Mg2+] was less than that of PCr
recovery measurements, and may reflect the sensitivity of these measurements to phasing errors.
In addition, prior exercise is unlikely to alter measurements of resting metabolites or muscle
metabolism suggesting that rigorous control of physical activity prior to metabolic testing is
unnecessary.
Background
Magnesium is a relatively abundant element in the body
that is important in a number of metabolic reactions[1]. A
number of factors may change magnesium levels in the
body. Physical activity may deplete magnesium concen-
trations which could lead to reduced exercise capacity [2-
4]. In addition magnesium concentrations have been
linked to changes in immune function and disease [5].
Many of the studies on magnesium have been made on
serum and RBC magnesium concentrations[6,7], but
other studies have suggested that magnesium levels in
other tissues may also be important[8].
Intracellular magnesium concentrations [Mg2+] have been
measured non-invasively in brain and skeletal muscles
using  31P MRS[9,10]. This method is based on the fre-
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quency shift of the β-ATP peak caused by physiological
concentrations of [Mg2+]. Alterations in either blood or
muscle [Mg2+] have been reported in various patient pop-
ulation groups [10-13]. Several previous studies have sug-
gested that patients with enhanced fatigue have altered
intramuscular magnesium levels [14,15]. While these
studies appear promising, relatively few other investiga-
tors have evaluated potential changes in [Mg2+].
A potential limitation to using 31P MRS measurements to
calculate changes in [Mg2+] is that this method depends
on relatively small frequency shifts in the β-ATP peak,
which could potentially increase the variability of the
measurement. It is also not clear how physical activity
might influence [Mg2+] measurements. Strenuous exercise
that alters immune function might be expected to alter
[Mg2+], but it is less clear how relatively normal levels of
physical activity might influence measurements of [Mg2+].
Similarly, it is not clear how prior physical activity influ-
ences measurements of muscle oxidative metabolism.
Strenuous exercise which results in muscle injury or ATP
loss might impair muscle metabolism as measured by the
ratio of inorganic phosphate to phosphocreatine (PCr)
during steady level exercise[16,17]. However, short dura-
tion acute exercise did not alter the rate of PCr resynthesis
(a marker of oxidative metabolism)[18]. Subjects under-
going 31P MRS testing might be active during the day prior
to testing or even have to walk considerable distances to
reach the testing facility. It is not clear what kind of recom-
mendations concerning prior physical activity are needed
before 31P MRS testing can be performed.
The purpose of this study was to: 1) determine the repro-
ducibility of measurements of [Mg2+] and muscle oxida-
tive metabolism using 31P MRS, and 2) determine if
[Mg2+] and PCr recovery kinetics are influenced by prior
exercise. It was hypothesized that the reproducibility of
[Mg2+] would be similar to that of PCr recovery kinetics,
and that walking exercise of long duration prior to 31P
MRS testing would change [Mg2+] and slow PCr recovery
kinetics.
Methods
A total of 12 healthy, college aged males (mean age = 22
± 1.9 yrs) participated in this study (Table 1). All subjects
participated in physical activity at least twice a week. The
study was conducted with the approval of the Institu-
tional Review Board at the University of Georgia and all
subjects provided written informed consent.
This study used a one group with repeated measures
experimental design. Each subject was tested on four sep-
arate days, plus one familiarization testing session (Figure
1). Each test day was separated by 1-30 days. The testing
sessions consisted of 31P MRS measurements of resting
[Mg2+] and muscle metabolism. Prior to test session three,
the subjects performed inclined treadmill walking for two
hours. Test session four was performed one to three days
post exercise. Each subject reported no physical activity
twenty-four hours prior to testing other than the exercise
performed in this study.
Familiarization session
A familiarization session was used to instruct the subjects
how to perform the maximal isometric contractions
(MVIC) in a supine position for 39 seconds. Subjects were
positioned supine on a table and instructed to maximally
contract the quadriceps muscle. Each subject performed
two 20 second maximal contractions and two 40 second
maximal contractions with approximately five minutes
between contractions. To encourage maximal muscle acti-
vation, EMG signals were recorded from the vastus latera-
lis muscle and the subjects were allowed to view the
signals. To predict if the contraction was vigorous enough
to deplete PCr, the decline in oxygen saturation in the vas-
tus lateralis muscle was measured during the maximal iso-
metric contractions using continuous wavelength near-
infrared spectroscopy (NIRS) [19].
Intramuscular magnesium
Subjects were placed in a 3 Tesla whole body magnet (GE
Healthcare, Waukesha, WI). A 1H and 31P dual radio-fre-
quency (RF) surface coil (Clinical MR Solutions, Brook-
field, WI.) was placed over the vastus lateralis of the
subject's right leg. The size of the 31P coil was 13 cm × 13
cm with an overlapping 1H coil (two loops, side by side,
20 cm diameter). Manual shimming on 1H was applied to
get a better signal-to-noise ratio (SNR) and less spectrum
distortion, after an auto-shimming by a pre-scan
sequence. A free induction decay (FID) chemical shift
imaging (CSI) pulse sequence was applied to acquire the
31P spectrum. The scan parameters were: repetition time
(TR) = 3000 ms, field-of-view (FOV) = 18 cm, slice thick-
ness = 100 mm, number of excitation (NEX) = 1, rfpulse =
hard. Resting spectra were acquired every 3 seconds until
120 scans were taken. The resulting spectra were zero
filled (from 2048 to 6144 points) phased and averaged in
a custom analysis program (Winspa, Ronald Meyer, Mich-
igan State University). The area under the curve for each
peak (Pi, PDE, PCr, α ATP, β-ATP, and γ-ATP) was deter-
Table 1: Subject characteristics
Subject characteristics Physical activity
Age Height Weight Min/week
Years Cm Kg Light Moderate Heavy
Mean 22 179 82 131 76 30
SD 1.9 3.7 33.1 78.5 42.3 31.8
n = 12, all male.Dynamic Medicine 2009, 8:5 http://www.dynamic-med.com/content/8/1/5
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mined using integration. Magnesium and pH were calcu-
lated using the following equations:
where shiftβ-ATP and shiftpi represent a shift of the peak Pi
and β-ATP in the spectrum, respectively.
Phosphocreatine recovery kinetics
Muscle metabolism was measured using rate of recovery
of PCr after exercise [15]. After resting measurements of
[Mg2+] and ATP were taken, the subject performed a 30-39
second duration MVIC to deplete PCr. The subject was
then instructed to remain as still as possible while recov-
ery data was collected for approximately four minutes.
This procedure was repeated two or three times. Phospho-
creatine peaks were determined from peak heights from
individual spectra using a custom Matlab (The Math-
works, Natick, MA.) routine. PCr peak heights during
recovery after exercise were fit to an exponential curve:
where A, B, and Tc are fitting parameters describing the
PCr depletion.
Exercise protocol
Incline treadmill walking was performed for two hours
where the subjects reached a target work level that was
between 40-60% percent of their heart rate reserve. Peri-
odically during the walking, speed/grade variations, EMG
activity, heart rate and perceived exertion were collected.
EMG activity during walking was normalized to a MVIC
performed prior to walking. Speed was adjusted between
3-5 mph and grade between 5-8% during the walking to
ensure the testing remained at a consistent exercise inten-
sity. Subjects were allowed to drink 32 ounces of water or
a sports beverage while walking.
Statistical analysis
All values are reported as means ± standard deviation.
Repeated measures ANOVA and Reliability measures
(SPSS) were conducted to evaluate the variation between
and within days. A linear regression was used to evaluate
whether oxygen saturation as a percentage of exercise
could predict a person's end exercise PCr. Analyses were
conducted with statistical significance accepted at α  <
0.05. ICC values were calculated from a one way ANOVA,
where the values were for each of the first two days. R =
(mean square between - mean square within)/(mean
square between + mean square within). The COV% was
calculated as the standard deviation of the value for the
first two days divided by the average value times 100%.
Results
Isometric contractions
All subjects in the study were able to consistently perform
maximal MVIC contractions of their right leg during the
familiarization session. This was evidenced by consist-
ently high EMG signals and consistent depletion of oxy-
gen saturation as measured by NIRS (end exercise oxygen
saturations of 47 ± 20% compared to a resting value of 83
± 4.6%).
31P MRS measurements
Representative  31P spectra are shown in Figure 2. The
mean resting phosphocreatine signal to noise ratio for all
subjects was 47:1. A signal to noise ratio for phosphocre-
atine of 7:1 for individual spectra was set as exclusion cri-
teria. Based on exclusion criteria for Mg and ATP
concentration, all twelve subjects were analyzed. Table 2
shows the average values for the phosphorous peaks and
for pH during the different trials both at rest and at the
end of the in magnet exercise protocol.
Intramuscular magnesium concentrations
Magnesium concentrations during the four test sessions
are shown in Table 3. Mauchly's W was significant (W =
0.030, p < 0.001), indicating unequal variance between
testing sessions. This was a result of the two outlying val-
ues (0.57 and 0.24 mM) occurring in the first test results.
These differences were consistent when the data was ana-
pMg shift shift ATP ATP =− − () −+ () −− 42 4 1 85 8 1 57 4
04 2 08 4
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Study time line Figure 1
Study time line. The subjects were tested on five separate days. The first day was used as a training session outside the mag-
net. The remaining four days involved testing in the magnet.Dynamic Medicine 2009, 8:5 http://www.dynamic-med.com/content/8/1/5
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lyzed with two independent observers. After using a
Greenhouse-Geisser correction for unequal variance,
there was no statistically significant differences in [Mg2+]
between the four test sessions (p = 0.440). This did not
support the hypothesis that [Mg2+] would change as a
result of the exercise session.
Muscle metabolism measured with PCr recovery kinetics
Figure 3 shows a representative recovery curve for phos-
phocreatine after exercise. PCr recovery data were used in
the analysis if the exercise resulted in a depletion of at
least 20% of PCr, and the curve fit of the recovery of PCr
had an r2 value above 0.6. Eleven of the twelve subjects
had data that fit these criteria for all time points. PCr
recovery time constants are shown in Table 4. There were
no statistically significant differences in the PCr recovery
kinetics (F = 0.206, p = 0.892, df = 3) between the four test
days using ANOVA. This did not support the hypothesis
that PCr recovery kinetics would change as a result of the
exercise session. The correlation coefficient for PCr Tc val-
ues and [Mg2+] values averaged over the first two test ses-
sions as low, R2 < 0.02.
Discussion
This study found that the reproducibility of resting [Mg2+]
a s  m e a s u r e d  b y  C O V %  ( 7 . 9 % )  t o  b e  c o n s i s t e n t  w i t h
although slightly higher than literature values of 6.1%
[20] and 4.1% [21]. One reason for the slightly higher var-
iability in our study was the presence of the highest (0.57
mM) and lowest (0.24 mM) [Mg2+] values in the first test-
ing session. Without these high/low values, the mean and
standard deviation of the first test session was similar to
the other test days. We have no explanation for these out-
lying values, and separate analysis of all the data by a dif-
ferent investigator did not change the pattern of the
results. Variability reported as ICC values were lower than
what is expected for data that is considered to have ade-
quate reproducibility (0.362, which is below 0.70). The
COV% and ICC values illustrate what we think is an
important aspect of the [Mg2+] measurements. The good
COV% suggests that the [Mg2+] are reproducible. The low
ICC values on the other hand suggest there is little differ-
ence between [Mg2+] values between healthy control sub-
jects. Thus, [Mg2+] measurements might be useful for
detecting differences in patient populations where [Mg2+]












Pre 1 Mean 0.089 4.24 7.07 46.1 6.94
SD 0.029 0.66 0.03 11.6 0.07
Pre 2 Mean 0.092 4.68 7.06 52.0 6.97
SD 0.012 0.98 0.02 14.0 0.10
Post 1 Mean 0.080 5.14 7.06 48.9 6.98
SD 0.017 0.98 0.02 14.0 0.10
Post 2 Mean 0.092 5.12 7.05 43.5 6.98
SD 0.023 1.08 0.02 7.8 0.08
ICC pre 1&2 0.13 0.79 .021 0.87 .064
COV% pre 1&2 15.1 8.60 0.21 11.1 0.79
Representative resting and end exercise spectra from one subject Figure 2
Representative resting and end exercise spectra from one subject. Each spectra is one average with a repetition time 
of 3 seconds.Dynamic Medicine 2009, 8:5 http://www.dynamic-med.com/content/8/1/5
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might be expected to change [10-15], but not for detecting
differences within normal healthy populations.
The actual values for [Mg2+] were consistent between our
current study (0.39 mM) and our previous study (0.37
mM) [13], despite using a different muscle (vastus latera-
lis versus the gastrocnemius muscle) and a different mag-
net/spectrometer system. These values are slightly higher
than found in several other previous studies (0.31 and
0.32 mM) [12,22], although they are are lower than values
(0.56 mM) from the calf by Ryschon et al. [20]. We used
the same equation for determining [Mg2+] as did[12,22].
However, Ryschon et al. [20] used a different equation to
determine [Mg2+], which used the frequency shifts
between the ATP peaks[23] rather than between PCr and
the beta ATP peak as in this study. Because the frequency
shift between PCr and beta ATP was similar between our
study (-15.85 to -16.03 ppm) and that of Ryschon et al. (-
15.9 to -16.1 ppm) [20], it is most likely the equation
used rather than measurement differences that explain the
differences in concentrations found.
We found that measurements of intramuscular magne-
sium were not affected by prior exercise. Numerous stud-
ies have reported sweat, urinary, and blood magnesium
changes with exercise [1,4,24]. Increases in urinary mag-
nesium excretion [25] and decreases in serum magnesium
levels [26] have been reported after running a marathon.
Muscle magnesium may increase after exercise[1,27].
Changes in magnesium concentrations with exercise
could be due to dehydration and redistribution of magne-
sium around the body, or be related to inflammatory
responses related to exercise[28]. The exercise used in this
study may not have activated the quadriceps muscles
enough to directly influence muscle magnesium. This is
because only a small amount of the quadriceps muscle is
actually active during walking (we estimated this to be
around 2% based on EMG signals). However, marathon
running was shown to change serum magnesium concen-
trations. Our exercise protocol was two hours in duration,
and while classified as a moderate intensity, was designed
to produce a reasonable amount of stress on the body. It
maybe that future studies will need to use exercise that
activates the target muscle more, or a more strenuous exer-
cise designed to produce a large immune response. Our
results do suggest that it is not necessary to strictly control
activity levels of subjects prior to making intramuscular
magnesium measurements. Two hours of moderate inten-
sity walking is more than most potential research subjects
would perform prior to testing.
This study found no relationship between intracellular
magnesium levels and muscle metabolism measured by
PCr recovery kinetics. Previous studies have suggested that
since magnesium in a primary stabilizing cofactor in ATP
dependent reactions [1], changes in bound magnesium
levels may alter the phosphorylation and dephosphoryla-
tion of mitochondrial ATP [9]. The phosphate from the
mitochondrial ATP is used to rephosphorylate PCr; there-
fore, changes in this oxidative metabolism may be
reflected through magnesium concentrations and/or
phosphocreatine recovery kinetics. The finding that base-
line measurements of [Mg2+] did not correlate with the
PCr Tc, which did have an acceptable ICC values, support
the previous discussion that magnesium measurements
maybe more useful in detecting abnormal populations or
conditions rather than differences between healthy
younger subjects as tested in this study.
The reproducibility of our PCr recovery kinetics was simi-
lar to that reported in previous studies[29]. We found a
COV% of 8% within a test session and 18% between test
Table 3: [Mg+2] changes pre/post exercise




Mean 0.414 0.376 0.386 0.375
SD 0.151 0.034 0.035 0.037
ICC b/t pre 1&2 0.352
COV% b/t pre 1&2 7.91
Representative PCr recovery curve after isometric exercise Figure 3
Representative PCr recovery curve after isometric 
exercise. Each data point is the peak PCr value for a single 
average spectra.Dynamic Medicine 2009, 8:5 http://www.dynamic-med.com/content/8/1/5
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sessions. Walter et al [18] tested four people on two differ-
ent days and found a kpcr COV% of 8-10% for varying
workloads and durations in the calf muscle. Larson-Meyer
et al. [30] found a COV% of 5.0 ± 2.9 s after testing the calf
of eight female subjects one month apart. Unlike the
[Mg2+] measurements, the ICC values for PCr recovery
time constants were above 0.70, indicating a good ability
to detect differences between normal healthy subjects.
The PCr recovery time constant was not influenced by two
hours of vigorous walking. In previous studies, repeated
bouts of short duration exercise did not alter PCr recovery
kinetics [31], and strenuous exercise performed two days
prior to the measurements did not alter PCr recovery in
either normal controls or people with chronic fatigue syn-
drome [15]. Walter et al. [18] also measured PCr recovery
kinetics in the gastrocnemius of eight male subjects, meas-
ured as Vmax, with and without a warm-up and did not
find a significant difference in the times to recovery.
Together these results suggest that both PCr recovery
kinetics as well as intramuscular magnesium measure-
ments are relatively insensitive to prior physical activity.
The PCr recovery measurements differed from previous
studies in that we did not use an in magnet ergometer. The
use of a MVIC is advantageous because it does not require
a special in-magnetic ergometer. This type of exercise was
considered unusual by the research subjects and thus we
felt that a familiarization test session was needed. We did
not find that oxygen saturation values measured during
this test were useful in predicting which subjects would
deplete the most PCr during the in-magnet tests. However
the use of EMG signal did seem to have a small effect on
the subjects' ability to activate their vastus lateralis mus-
cles. We found that a MVIC of the quadriceps was suffi-
cient to deplete PCr and generate a mono-exponential
recovery curve. Measurements of PCr using 31P MRS have
been shown to agree with measurements from biopsies
[32], and the recovery rate of PCr has been correlated with
biopsy measurements of mitochondrial enzymes[33].
Thus, we feel the use of isometric contractions to deplete
PCr, with the subsequent measurement of PCr recovery
rates is an acceptable method of measuring muscle metab-
olism.
Conclusions
We found that measurements of [Mg2+] and PCr recovery
kinetics to be reproducible, but in different ways. [Mg2+]
have lower COV%, but also lower ICC indicating good
reproducibility but poor ability to detect differences
between healthy control subjects. PCr recovery kinetics
showed less reproducibility with COV%, but with an ade-
quate ability to detect differences between healthy control
subjects as shown by high ICC values. Neither [Mg2+] or
PCr recovery kinetics were influenced by 2 hours of vigor-
ous walking exercise. This may reflect the relatively low
activation of the vastus lateralis during vigorous walking.
It does suggest that limiting subject walking activity prior
to testing for [Mg2+] and PCr recovery kinetics is not nec-
essary.
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